Pharmacokinetics of Plasmid DNA-Based Non-viral Gene Medicine

Advances in Genetics

Volumn 53, Issue , 2005, Pages 47-68

  Nishikawa, Makiya ^a   Takakura, Yoshinobu ^a   Hashida, Mitsuru ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; LIPOSOME; POLYAMINE; POLYCATIONS;

GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETICS; INJECTION; MACROPHAGE; METHODOLOGY; PLASMID; REVIEW; TRANSGENE;

DNA; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; INJECTIONS; LIPOSOMES; MACROPHAGES; PLASMIDS; POLYAMINES; TRANSGENES;

EID: 33645242924     PISSN: 00652660     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2660(05)53003-7     Document Type: Review

References (99)

1. Adami R.C., Collard W.T., Gupta S.A., Kwok K.Y., Bonadio J., and Rice K.G. Stability of peptide-condensed plasmid DNA formulations. J. Pharm. Sci. 87 (1998) 678-683
2. Ali S.A., Eary J.F., Warren S.D., Badger C.C., and Krohn K.A. Synthesis and radioiodination of tyramine cellobiose for labeling monoclonal antibodies. Nucl. Med. Biol. 15 (1988) 557-561
3. Alila H., Coleman M., Nitta H., French M., Anwer K., Liu Q., Meyer T., Wang J., Mumper R., Oubari D., Long S., Nordstrom J., and Rolland A. Expression of biologically active human insulin-like growth factor-I following intramuscular injection of a formulated plasmid in rats. Hum. Gene Ther. 8 (1997) 1785-1795
4. Audouy S.A., de Leij L.F., Hoekstra D., and Molema G. In vivo characteristics of cationic liposomes as delivery vectors for gene therapy. Pharm. Res. 19 (2002) 1599-1605
5. Barron L.G., Meyer K.B., and Szoka Jr. F.C. Effects of complement depletion on the pharmacokinetics and gene delivery mediated by cationic lipid-DNA complexes. Hum. Gene Ther. 9 (1998) 315-323
6. Barry M.E., Pinto-Gonzalez D., Orson F.M., McKenzie G.J., Petry G.R., and Barry M.A. Role of endogenous endonucleases and tissue site in transfection and CpG-mediated immune activation after naked DNA injection. Hum. Gene Ther. 10 (1999) 2461-2480
7. Brigham K.L., Meyrick B., Christman B., Magnuson M., King G., and Berry Jr. L.C. In vivo transfection of murine lungs with a functioning prokaryotic gene using a liposome vehicle. Am. J. Med. Sci. 298 (1989) 278-281
8. Budker V., Zhang G., Knechtle S., and Wolff J.A. Naked DNA delivered intraportally expresses efficiently in hepatocytes. Gene Ther. 3 (1996) 593-598
9. Budker V., Zhang G., Danko I., Williams P., and Wolff J.A. The efficient expression of intravascularly delivered DNA in rat muscle. Gene Ther. 5 (1998) 272-276
10. Budker V., Budker T., Zhang G., Subbotin V., Loomis A., and Wolff J.A. Hypothesis: Naked plasmid DNA is taken up by cells in vivo by a receptor-mediated process. J. Gene Med. 2 (2000) 76-88
11. Deshpande S.V., Subramanian R., McCall M.J., DeNardo S.J., DeNardo G.L., and Meares C.F. Metabolism of indium chelates attached to monoclonal antibody: Minimal transchelation of indium from benzyl-EDTA chelate in vivo. J. Nucl. Med. 31 (1990) 218-224
12. Emlen W., Rifai A., Magilavy D., and Mannik M. Hepatic binding of DNA is mediated by a receptor on nonparenchymal cells. Am. J. Pathol. 133 (1988) 54-60
13. Felgner P.L., Barenholz Y., Behr J.P., Cheng S.H., Cullis P., Huang L., Jessee J.A., Seymour L., Szoka F., Thierry A.R., Wagner E., and Wu G. Nomenclature for synthetic gene delivery systems. Hum. Gene Ther. 8 (1997) 511-512
14. Finsinger D., Remy J.S., Erbacher P., Koch C., and Plank C. Protective copolymers for non-viral gene vectors: Synthesis, vector characterization and application in gene delivery. Gene Ther. 7 (2000) 1183-1192
15. Herzog R.W., Yang E.Y., Couto L.B., Hagstrom J.N., Elwell D., Fields P.A., Burton M., Bellinger D.A., Read M.S., Brinkhous K.M., Podsakoff G.M., Nichols T.C., Kurtzman G.J., and High K.A. Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector. Nat. Med. 5 (1999) 56-63
16. Hickman M.A., Malone R.W., Lehmann-Bruinsma K., Sih T.R., Knoell D., Szoka F.C., Walzem R., Carlson D.M., and Powell J.S. Gene expression following direct injection of DNA into liver. Hum. Gene Ther. 5 (1994) 1477-1483
17. Hisazumi J., Kobayashi N., Nishikawa M., and Takakura Y. Significant role of liver sinusoidal endothelial cells in hepatic uptake and degradation of naked plasmid DNA following intravenous injection. Pharm. Res. 21 (2004) 1223-1228
18. Houk B.E., Martin R., Hochhaus G., and Hughes J.A. Pharmacokinetics of plasmid DNA in the rat. Pharm. Res. 18 (2001) 67-74
19. Kawabata K., Takakura Y., and Hashida M. The fate of plasmid DNA after intravenous injection in mice: Involvement of scavenger receptors in its hepatic uptake. Pharm. Res. 12 (1995) 825-830
20. Kawakami S., Sato A., Nishikawa M., Yamashita F., and Hashida M. Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes. Gene Ther. 7 (2000) 292-299
21. Kawakami S., Fumoto S., Nishikawa M., Yamashita F., and Hashida M. In vivo gene delivery to the liver using novel galactosylated cationic liposomes. Pharm. Res. 17 (2000) 306-313
22. Kawakami S., Yamashita F., Nishida K., Nakamura J., and Hashida M. Glycosylated cationic liposomes for cell-selective gene delivery. Crit. Rev. Ther. Drug Carrier Syst. 19 (2002) 171-190
23. Kay M.A., Manno C.S., Ragni M.V., Larson P.J., Couto L.B., McClelland A., Glader B., Chew A.J., Tai S.J., Herzog R.W., Arruda V., Johnson F., Scallan C., Skarsgard E., Flake A.W., and High K.A. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nat. Genet. 24 (2000) 257-261
24. Kircheis R., Schuller S., Brunner S., Ogris M., Heider K.H., Zauner W., and Wagner E. Polycation-based DNA complexes for tumor-targeted gene delivery in vivo. J. Gene Med. 1 (1999) 111-120
25. Kircheis R., Blessing T., Brunner S., Wightman L., and Wagner E. Tumor targeting with surface-shielded ligand-polycation DNA complexes. J. Control. Release 72 (2001) 165-170
26. Kobayashi N., Kuramoto T., Yamaoka K., Hashida M., and Takakura Y. Hepatic uptake and gene expression mechanisms following intravenous administration of plasmid DNA by conventional and hydrodynamics-based procedures. J. Pharmacol. Exp. Ther. 297 (2001) 853-860
27. Kobayashi N., Nishikawa M., Hirata K., and Takakura Y. Hydrodynamics-based procedure involves transient hyperpermeability in the hepatic cellular membrane: Implication of a nonspecific process in efficient intracellular gene delivery. J. Gene Med. 6 (2004) 584-592
28. Kobayashi N., Hirata K., Chen S., Kawase A., Nishikawa M., and Takakura Y. Hepatic delivery of particulates in the submicron range by a hydrodynamics-based procedure: Implications for particulate gene delivery systems. J. Gene Med. 6 (2004) 455-463
29. Lechardeur D., Sohn K.J., Haardt M., Joshi P.B., Monck M., Graham R.W., Beatty B., Squire J., O'Brodovich H., and Lukacs G.L. Metabolic instability of plasmid DNA in the cytosol: A potential barrier to gene transfer. Gene Ther. 6 (1999) 482-497
30. Lecocq M., Andrianaivo F., Warnier M.T., Wattiaux-De Coninck S., Wattiaux R., and Jadot M. Uptake by mouse liver and intracellular fate of plasmid DNA after a rapid tail vein injection of a small or a large volume. J. Gene Med. 5 (2003) 142-156
31. Lew D., Parker S.E., Latimer T., Abai A.M., Kuwahara-Rundell A., Doh S.G., Yang Z.Y., Laface D., Gromkowski S.H., Nabel G.J., et al. Cancer gene therapy using plasmid DNA: Pharmacokinetic study of DNA following injection in mice. Hum. Gene Ther. 6 (1995) 553-564
32. Li S., Rizzo M.A., Bhattacharya S., and Huang L. Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery. Gene Ther. 5 (1998) 930-937
33. Li S., Tseng W.C., Stolz D.B., Wu S.P., Watkins S.C., and Huang L. Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: Implications for intravenous lipofection. Gene Ther. 6 (1999) 585-594
34. Li S., Tan Y., Viroonchatapan E., Pitt B.R., and Huang L. Targeted gene delivery to pulmonary endothelium by anti-PECAM antibody. Am. J. Physiol. 278 (2000) L504-L511
35. Liang K.W., Nishikawa M., Liu F., Sun B., Ye Q., and Huang L. Restoration of dystrophin expression in mdx mice by intravascular injection of naked DNA containing full-length dystrophin cDNA. Gene Ther. 11 (2004) 901-908
36. Lin H., Parmacek M.S., Morle G., Bolling S., and Leiden J.M. Expression of recombinant genes in myocardium in vivo after direct injection of DNA. Circulation 82 (1990) 2217-2221
37. Litzinger D.C., Brown J.M., Wala I., Kaufman S.A., Van G.Y., Farrell C.L., and Collins D. Fate of cationic liposomes and their complex with oligonucleotide in vivo. Biochim. Biophys. Acta 1281 (1996) 139-149
38. Liu Y., Mounkes L.C., Liggitt H.D., Brown C.S., Solodin I., Heath T.D., and Debs R.J. Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery. Nat. Biotechnol. 15 (1997) 167-173
39. Liu F., Song Y., and Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 6 (1999) 1258-1266
40. Mahato R.I., Kawabata K., Nomura T., Takakura Y., and Hashida M. Physicochemical and pharmacokinetic characteristics of plasmid DNA/cationic liposome complexes. J. Pharm. Sci. 84 (1995) 1267-1271
41. Mahato R.I., Anwer K., Tagliaferri F., Meaney C., Leonard P., Wadhwa M.S., Logan M., French M., and Rolland A. Biodistribution and gene expression of lipid/plasmid complexes after systemic administration. Hum. Gene Ther. 9 (1998) 2083-2099
42. Manno C.S., Chew A.J., Hutchison S., Larson P.J., Herzog R.W., Arruda V.R., Tai S.J., Ragni M.V., Thompson A., Ozelo M., Couto L.B., Leonard D.G., Johnson F.A., McClelland A., Scallan C., Skarsgard E., Flake A.W., Kay M.A., High K.A., and Glader B. AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood 101 (2003) 2963-2972
43. McLean J.W., Fox E.A., Baluk P., Bolton P.B., Haskell A., Pearlman R., Thurston G., Umemoto E.Y., and McDonald D.M. Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in mice. Am. J. Physiol. 273 (1997) H387-H404
44. Morimoto K., Nishikawa M., Kawakami S., Nakano T., Hattori Y., Fumoto S., Yamashita F., and Hashida M. Molecular weight-dependent gene transfection activity of unmodified and galactosylated polyethyleneimine on hepatoma cells and mouse liver. Mol. Ther. 7 (2003) 254-261
45. Morishita R., Aoki M., Hashiya N., Makino H., Yamasaki K., Azuma J., Sawa Y., Matsuda H., Kaneda Y., and Ogihara T. Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease. Hypertension 44 (2004) 203-209
46. Nakamura M., Davila-Zavala P., Tokuda H., Takakura Y., and Hashida M. Uptake and gene expression of naked plasmid DNA in cultured brain microvessel endothelial cells. Biochem. Biophys. Res. Commun. 245 (1998) 235-239
47. Nara E., Masegi M., Hatono T., and Hashida M. Pharmacokinetic analysis of drug absorption from muscle based on a physiological diffusion model: Effect of molecular size on absorption. Pharm. Res. 9 (1992) 161-168
48. Neves C., Byk G., Escriou V., Bussone F., Scherman D., and Wils P. Novel method for covalent fluorescent labeling of plasmid DNA that maintains structural integrity of the plasmid. Bioconjug. Chem. 11 (2000) 51-55
49. Nishikawa M., and Hashida M. Non-viral approaches satisfying various requirements for effective in vivo gene therapy. Biol. Pharm. Bull. 25 (2002) 275-283
50. Nishikawa M., and Huang L. Non-viral vectors in the new millennium: Delivery barriers in gene transfer. Hum. Gene Ther. 12 (2001) 861-870
51. Nishikawa M., Takakura Y., and Hashida M. Pharmacokinetic evaluation of polymeric carriers. Adv. Drug Delivery Rev. 21 (1996) 135-155
52. Nishikawa M., Takemura S., Takakura Y., and Hashida M. Targeted delivery of plasmid DNA to hepatocytes in vivo: optimization of the pharmacokinetics of plasmid DNA/galactosylated poly(L-lysine) complexes by controlling their physicochemical properties. J. Pharmacol. Exp. Ther. 287 (1998) 408-415
53. Nishikawa M., Yamauchi M., Morimoto K., Ishida E., Takakura Y., and Hashida M. Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system. Gene Ther. 7 (2000) 548-555
54. Nishikawa M., Nakano T., Okabe T., Hamaguchi N., Yamasaki Y., Takakura Y., Yamashita F., and Hashida M. Residualizing indium-111-radiolabel for plasmid DNA and its application to tissue distribution study. Bioconjug. Chem. 14 (2003) 955-961
55. Nomura T., Nakajima S., Kawabata K., Yamashita F., Takakura Y., and Hashida M. Intratumoral pharmacokinetics and in vivo gene expression of naked plasmid DNA and its cationic liposome complexes after direct gene transfer. Cancer Res. 57 (1997) 2681-2686
56. Nomura T., Yasuda K., Yamada T., Okamoto S., Mahato R.I., Watanabe Y., Takakura Y., and Hashida M. Gene expression and antitumor effects following direct interferon (IFN)-gamma gene transfer with naked plasmid DNA and DC-chol liposome complexes in mice. Gene Ther. 6 (1999) 121-129
57. Ogris M., Brunner S., Schuller S., Kircheis R., and Wagner E. PEGylated DNA/transferrin-PEI complexes: Reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther. 6 (1999) 595-605
58. Oh Y.K., Kim J.P., Yoon H., Kim J.M., Yang J.S., and Kim C.K. Prolonged organ retention and safety of plasmid DNA administered in polyethylenimine complexes. Gene Ther. 8 (2001) 1587-1592
59. O'Hara A.J., Howell J.M., Taplin R.H., Fletcher S., Lloyd F., Kakulas B., Lochmuller H., and Karpati G. The spread of transgene expression at the site of gene construct injection. Muscle Nerve 24 (2001) 488-495
60. Ono T., Fujino Y., Tsuchiya T., and Tsuda M. Plasmid DNAs directly injected into mouse brain with lipofectin can be incorporated and expressed by brain cells. Neurosci. Lett. 117 (1990) 259-263
61. Oupicky D., Ogris M., Howard K.A., Dash P.R., Ulbrich K., and Seymour L.W. Importance of lateral and steric stabilization of polyelectrolyte gene delivery vectors for extended systemic circulation. Mol. Ther. 5 (2002) 463-472
62. Perales J.C., Ferkol T., Beegen H., Ratnoff O.D., and Hanson R.W. Gene transfer in vivo: Sustained expression and regulation of genes introduced into the liver by receptor-targeted uptake. Proc. Natl. Acad. Sci. USA 91 (1994) 4086-4090
63. Piatyszek M.A., Jarmolowski A., and Augustyniak J. Iodo-Gen-mediated radioiodination of nucleic acids. Anal. Biochem. 172 (1988) 356-359
64. Plautz G.E., Yang Z.Y., Wu B.Y., Gao X., Huang L., and Nabel G.J. Immunotherapy of malignancy by in vivo gene transfer into tumors. Proc. Natl. Acad. Sci. USA 90 (1993) 4645-4649
65. 2+-sensitive cytosolic nucleases prevent efficient delivery to the nucleus of injected plasmids. J. Gene Med. 3 (2001) 153-164
66. Raz E., Carson D.A., Parker S.E., Parr T.B., Abai A.M., Aichinger G., Gromkowski S.H., Singh M., Lew D., Yankauckas M.A., et al. Intradermal gene immunization: The possible role of DNA uptake in the induction of cellular immunity to viruses. Proc. Natl. Acad. Sci. USA 91 (1994) 9519-9523
67. Rigby P.W., Dieckmann M., Rhodes C., and Berg P. Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. J. Mol. Biol. 113 (1977) 237-251
68. Roth D.A., Tawa Jr. N.E., O'Brien J.M., Treco D.A., and Selden R.F. Non-viral transfer of the gene encoding coagulation factor VIII in patients with severe hemophilia A. N Engl. J. Med. 344 (2001) 1735-1742
69. Sakurai F., Nishioka T., Saito H., Baba T., Okuda A., Matsumoto O., Taga T., Yamashita F., Takakura Y., and Hashida M. Interaction between DNA-cationic liposome complexes and erythrocytes is an important factor in systemic gene transfer via the intravenous route in mice: The role of the neutral helper lipid. Gene Ther. 8 (2001) 677-686
70. Sakurai F., Nishioka T., Yamashita F., Takakura Y., and Hashida M. Effects of erythrocytes and serum proteins on lung accumulation of lipoplexes containing cholesterol or DOPE as a helper lipid in the single-pass rat lung perfusion system. Eur. J. Pharm. Biopharm. 52 (2001) 165-172
71. Sakurai F., Terada T., Yasuda K., Yamashita F., Takakura Y., and Hashida M. The role of tissue macrophages in the induction of proinflammatory cytokine production following intravenous injection of lipoplexes. Gene Ther. 9 (2002) 1120-1126
72. Satkauskas S., Bureau M.F., Mahfoudi A., and Mir L.M. Slow accumulation of plasmid in muscle cells: Supporting evidence for a mechanism of DNA uptake by receptor-mediated endocytosis. Mol. Ther. 4 (2001) 317-323
73. Sikes M.L., O'Malley Jr. B.W., Finegold M.J., and Ledley F.D. In vivo gene transfer into rabbit thyroid follicular cells by direct DNA injection. Hum. Gene Ther. 5 (1994) 837-844
74. Slattum P.S., Loomis A.G., Machnik K.J., Watt M.A., Duzeski J.L., Budker V.G., Wolff J.A., and Hagstrom J.E. Efficient in vitro and in vivo expression of covalently modified plasmid DNA. Mol. Ther. 8 (2003) 255-263
75. Snyder R.O., Miao C., Meuse L., Tubb J., Donahue B.A., Lin H.F., Stafford D.W., Patel S., Thompson A.R., Nichols T., Read M.S., Bellinger D.A., Brinkhous K.M., and Kay M.A. Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors. Nat. Med. 5 (1999) 64-70
76. Takagi T., Hashiguchi M., Mahato R.I., Tokuda H., Takakura Y., and Hashida M. Involvement of specific mechanism in plasmid DNA uptake by mouse peritoneal macrophages. Biochem. Biophys. Res. Commun. 245 (1998) 729-733
77. Takakura Y., Takagi T., Hashiguchi M., Nishikawa M., Yamashita F., Doi T., Imanishi T., Suzuki H., Kodama T., and Hashida M. Characterization of plasmid DNA binding and uptake by peritoneal macrophages from class A scavenger receptor knockout mice. Pharm. Res. 16 (1999) 503-508
78. Terebesi J., Kwok K.Y., and Rice K.G. Iodinated plasmid DNA as a tool for studying gene delivery. Anal. Biochem. 263 (1998) 120-123
79. Terpstra V., van Amersfoort E.S., van Velzen A.G., Kuiper J., and van Berkel T.J. Hepatic and extrahepatic scavenger receptors: Function in relation to disease. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1860-1872
80. Thorpe S.R., Baynes J.W., and Chroneos Z.C. The design and application of residualizing labels for studies of protein catabolism. FASEB J. 7 (1993) 399-405
81. Verbaan F.J., Oussoren C., Snel C.J., Crommelin D.J., Hennink W.E., and Storm G. Steric stabilization of poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes mediates prolonged circulation and tumor targeting in mice. J. Gene Med. 6 (2004) 64-75
82. Wagner E., Plank C., Zatloukal K., Cotten M., and Birnstiel M.L. Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: Toward a synthetic virus-like gene-transfer vehicle. Proc. Natl. Acad. Sci. USA 89 (1992) 7934-7938
83. Ward C.M., Pechar M., Oupicky D., Ulbrich K., and Seymour L.W. Modification of pLL/DNA complexes with a multivalent hydrophilic polymer permits folate-mediated targeting in vitro and prolonged plasma circulation in vivo. J. Gene Med. 4 (2002) 536-547
84. Wasan E.K., Reimer D.L., and Bally M.B. Plasmid DNA is protected against ultrasonic cavitation-induced damage when complexed to cationic liposomes. J. Pharm. Sci. 85 (1996) 427-433
85. Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A., and Felgner P.L. Direct gene transfer into mouse muscle in vivo. Science 247 (1990) 1465-1468
86. Wu G.Y., and Wu C.H. Receptor-mediated gene delivery and expression in vivo. J. Biol. Chem. 263 (1988) 14621-14624
87. Xu Y., and Szoka Jr. F.C. Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry 35 (1996) 5616-5623
88. Yamasaki Y., Sumimoto K., Nishikawa M., Yamashita F., Yamaoka K., Hashida M., and Takakura Y. Pharmacokinetic analysis of in vivo disposition of succinylated proteins targeted to liver nonparenchymal cells via scavenger receptors: Importance of molecular size and negative charge density for in vivo recognition by receptors. J. Pharmacol. Exp. Ther. 301 (2002) 467-477
89. Yamasaki Y., Hisazumi J., Yamaoka K., and Takakura Y. Efficient scavenger receptor-mediated hepatic targeting of proteins by introduction of negative charges on the proteins by aconitylation: The influence of charge density and size of the proteins molecules. Eur. J. Pharm. Sci. 18 (2003) 305-312
90. Yang J.P., and Huang L. Overcoming the inhibitory effect of serum on lipofection by increasing the charge ratio of cationic liposome to DNA. Gene Ther. 4 (1997) 950-960
91. Yoo J.J., Soker S., Lin L.F., Mehegan K., Guthrie P.D., and Atala A. Direct in vivo gene transfer to urological organs. J. Urol. 162 (1999) 1115-1118
92. Yoshida M., Mahato R.I., Kawabata K., Takakura Y., and Hashida M. Disposition characteristics of plasmid DNA in the single-pass rat liver perfusion system. Pharm. Res. 13 (1996) 599-603
93. Yoshinaga T., Yasuda K., Ogawa Y., and Takakura Y. Efficient uptake and rapid degradation of plasmid DNA by murine dendritic cells via a specific mechanism. Biochem. Biophys. Res. Commun. 299 (2002) 389-394
94. Zelphati O., Liang X., Hobart P., and Felgner P.L. Gene chemistry: Functionally and conformationally intact fluorescent plasmid DNA. Hum. Gene Ther. 10 (1999) 15-24
95. Zhang G., Vargo D., Budker V., Armstrong N., Knechtle S., and Wolff J.A. Expression of naked plasmid DNA injected into the afferent and efferent vessels of rodent and dog livers. Hum. Gene Ther. 8 (1997) 1763-1772
96. Zhang G., Budker V., and Wolff J.A. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum. Gene Ther. 10 (1999) 1735-1737
97. Zhang G., Budker V., Williams P., Subbotin V., and Wolff J.A. Efficient expression of naked DNA delivered intraarterially to limb muscles of nonhuman primates. Hum. Gene Ther. 12 (2001) 427-438
98. Zhang G., Gao X., Song Y.K., Vollmer R., Stolz D.B., Gasiorowski J.Z., Dean D.A., and Liu D. Hydroporation as the mechanism of hydrodynamic delivery. Gene Ther. 11 (2004) 675-682
99. Zhu F.G., Reich C.F., and Pisetsky D.S. The role of the macrophage scavenger receptor in immune stimulation by bacterial DNA and synthetic oligonucleotides. Immunology 103 (2001) 226-234